Saudi Arabia

The Saudi Food and Drug Authority (SFDA) is the primary regulatory body responsible for overseeing the registration and market authorization of health products in Saudi Arabia, including pharmaceuticals, medical devices, diagnostics, and digital health solutions. Established under Royal Decree M/13 in 2003, the SFDA operates under a comprehensive legislative framework that includes the Drug Establishment and Products Law and associated regulations governing each product category. The general approval process requires applicants to submit a registration dossier through the SFDA's online GHAD or MDMA portals (depending on product type), followed by administrative screening, technical review, and, where necessary, product testing or facility inspection before a marketing authorization is granted.

All applications must be submitted through a licensed local regulatory agent or a legally registered Saudi entity acting as the market authorization holder, as foreign companies cannot hold registrations directly. Pharmaceutical dossiers are expected to follow the Common Technical Document (CTD) format aligned with ICH guidelines, while medical device submissions follow a risk-based classification system consistent with IMDRF frameworks. The SFDA accepts reliance pathways, recognizing approvals from reference regulatory authorities such as the US FDA, EMA, Health Canada, and others within the Gulf Cooperation Council's Mutual Recognition Agreement (MRA) framework managed by the GCC Standardization Organization (GSO). In recent years, the SFDA has advanced digital transformation initiatives, including expedited review tracks for innovative and critical-need products and alignment with Vision 2030 healthcare modernization goals.

Public procurement of health products in Saudi Arabia is centrally coordinated through the Ministry of Health (MOH), which operates the largest public healthcare network in the country comprising hospitals, primary health care centers, and specialized facilities. The National Center for Government Procurement (NCGP), formerly known as the Government Tenders and Procurement Law body, oversees the regulatory framework for public tenders, mandating competitive bidding processes governed by the Government Tenders and Procurement Law (Royal Decree M/128). Large-scale pharmaceutical and medical supply procurement is frequently channeled through the MOH's General Directorate of Pharmaceutical Care and its centralized tendering unit, while other government entities such as the Ministry of National Guard Health Affairs, the Royal Commission for Jubail and Yanbu, and Saudi Aramco Medical Services independently manage their own procurement cycles. The Saudi Vision 2030 reform agenda has accelerated the privatization of certain healthcare segments and introduced public-private partnership (PPP) models, including the transformation of government hospitals into independent clusters managed by entities such as the National Company for Healthcare (Sehhaty) ecosystem.

The private healthcare sector in Saudi Arabia is substantial and growing, driven by mandatory health insurance requirements for expatriate and, increasingly, Saudi national employees. Private hospital groups, pharmacy chains, and diagnostic laboratory networks procure health products through direct commercial agreements with local distributors and authorized importers registered with the SFDA. Saudi Arabia is not a primary recipient of donor-funded health procurement mechanisms such as UNICEF supply division, the Global Fund, or Gavi, given its upper-middle to high-income status, and international development financing plays a minimal role in the local health market. However, the government has introduced local manufacturing preference policies under its National Industrial Development Program and Vision 2030 framework, offering incentives such as price premiums of up to 10 percent for locally manufactured products in public tenders, in-country value (ICV) scoring requirements, and active encouragement of technology transfer and joint venture arrangements with Saudi industrial partners.